{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T11:27:15Z","timestamp":1778758035502,"version":"3.51.4"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"47","license":[{"start":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:00:00Z","timestamp":1763683200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,11,21]]},"abstract":"<jats:p>\n                    Insulin-like growth factor binding proteins (IGFBPs) are important regulatory factors of bone metabolism. However, the association between IGFBPs and osteoporosis remains a subject of contention in observational studies. We conducted a 2-sample Mendelian randomization (MR) study to assess the causal relationship between IGFBP 1-7 and osteoporosis using publicly available genome-wide association study summary statistics. The IGFBP 1-7 datasets were derived from German cohort studies and were selected at the genome-wide significance level (\n                    <jats:italic toggle=\"yes\">P\u2005<\/jats:italic>\n                    &lt;\u20055\u2005\u00d7\u200510\n                    <jats:sup>-6<\/jats:sup>\n                    ). The osteoporosis dataset was obtained from the UK Biobank study and included 484,598 individuals of European ancestry. Inverse variance weighting (IVW) was used as the primary MR method to investigate the causal relationship between exposure and outcome. To make the conclusions more robust and reliable, we used Cochran Q statistics, MR-Egger regression, and leave-one-out analysis as sensitivity analyses. Based on the IVW results, we identified a causal relationship between IGFBP-2 and osteoporosis, in which IGFBP-2 prevented the development of osteoporosis (IVW,\n                    <jats:italic toggle=\"yes\">P\u2005<\/jats:italic>\n                    =\u2005.006; odds ratio\u2005=\u20050.998; \u03b2\u2005=\u2005\u22120.0022; 95% confidence interval: 0.996\u20130.999). However, the study did not show a significant causal relationship between the remaining 6 IGFBPs and osteoporosis (\n                    <jats:italic toggle=\"yes\">P\u2005<\/jats:italic>\n                    &gt;\u2005.05). In addition, the sensitivity analyses confirmed the findings in our study were robust. This MR study suggests a potential protective role of IGFBP-2 against osteoporosis and that it may serve as a biomarker or therapeutic target, although further research is needed.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000045227","type":"journal-article","created":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T15:01:58Z","timestamp":1764169318000},"page":"e45227","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Causal associations between insulin-like growth factor binding protein-1 to -7 and osteoporosis: A two-sample Mendelian randomization study"],"prefix":"10.1097","volume":"104","author":[{"given":"Peng","family":"Du","sequence":"first","affiliation":[{"name":"Department of Orthopedics, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tusheng","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Orthopedics, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ning","family":"Fan","sequence":"additional","affiliation":[{"name":"Department of Orthopedics, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baodong","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Orthopedics, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tianyi","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Orthopedics, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5472-9257","authenticated-orcid":false,"given":"Lei","family":"Zang","sequence":"additional","affiliation":[{"name":"Department of Orthopedics, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20260514","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1186\/s12967-023-04563-z","article-title":"Romosozumab in osteoporosis: yesterday, today and tomorrow.","volume":"21","author":"Wu","year":"2023","journal-title":"J Transl Med"},{"key":"R2-20260514","doi-asserted-by":"crossref","first-page":"106635","DOI":"10.1016\/j.phrs.2022.106635","article-title":"Cell death regulation: a new way for natural products to treat osteoporosis.","volume":"187","author":"Li","year":"2023","journal-title":"Pharmacol Res"},{"key":"R3-20260514","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1007\/s00198-017-3909-3","article-title":"Worldwide prevalence and incidence of osteoporotic vertebral fractures.","volume":"28","author":"Ballane","year":"2017","journal-title":"Osteoporos Int"},{"key":"R4-20260514","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1359\/jbmr.061113","article-title":"Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025.","volume":"22","author":"Burge","year":"2007","journal-title":"J Bone Miner Res"},{"key":"R5-20260514","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1001\/jama.2018.7498","article-title":"Screening for osteoporosis to prevent fractures: US preventive services task force recommendation statement.","volume":"319","author":"Curry","year":"2018","journal-title":"JAMA"},{"key":"R6-20260514","doi-asserted-by":"crossref","first-page":"e12752","DOI":"10.1111\/cpr.12752","article-title":"IGFBP7 acts as a negative regulator of RANKL-induced osteoclastogenesis and oestrogen deficiency-induced bone loss.","volume":"53","author":"Ye","year":"2020","journal-title":"Cell Prolif"},{"key":"R7-20260514","doi-asserted-by":"crossref","first-page":"101245","DOI":"10.1016\/j.molmet.2021.101245","article-title":"Insulin-like growth factors: ligands, binding proteins, and receptors.","volume":"52","author":"LeRoith","year":"2021","journal-title":"Mol Metab"},{"key":"R8-20260514","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s00467-004-1658-y","article-title":"The multi-functional role of insulin-like growth factor binding proteins in bone.","volume":"20","author":"Govoni","year":"2005","journal-title":"Pediatr Nephrol"},{"key":"R9-20260514","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.ecl.2012.04.013","article-title":"The insulin-like growth factor system in bone: basic and clinical implications.","volume":"41","author":"Kawai","year":"2012","journal-title":"Endocrinol Metab Clin North Am"},{"key":"R10-20260514","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0953-6205(02)00183-8","article-title":"Serum levels of insulin-like growth factor (IGF)-I and IGF binding protein (IGFBP)-1 to -6 and their relationship to bone metabolism in osteoporosis patients.","volume":"14","author":"Jehle","year":"2003","journal-title":"Eur J Intern Med"},{"key":"R11-20260514","doi-asserted-by":"crossref","first-page":"E10","DOI":"10.1152\/ajpendo.00648.2007","article-title":"Insulin-like growth factor-binding proteins and bone metabolism.","volume":"294","author":"Conover","year":"2008","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"R12-20260514","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1210\/en.2017-00908","article-title":"What happened to the IGF binding proteins?","volume":"159","author":"Bach","year":"2018","journal-title":"Endocrinology"},{"key":"R13-20260514","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.puhe.2016.12.033","article-title":"\u2018Mendelian randomization\u2019: an approach for exploring causal relations in epidemiology.","volume":"145","author":"Gupta","year":"2017","journal-title":"Public Health"},{"key":"R14-20260514","doi-asserted-by":"crossref","first-page":"k601","DOI":"10.1136\/bmj.k601","article-title":"Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians.","volume":"362","author":"Davies","year":"2018","journal-title":"BMJ"},{"key":"R15-20260514","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s10654-015-0011-z","article-title":"Using published data in Mendelian randomization: a blueprint for efficient identification of causal risk factors.","volume":"30","author":"Burgess","year":"2015","journal-title":"Eur J Epidemiol"},{"key":"R16-20260514","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/gepi.21965","article-title":"Consistent estimation in mendelian randomization with some invalid instruments using a weighted median estimator.","volume":"40","author":"Bowden","year":"2016","journal-title":"Genet Epidemiol"},{"key":"R17-20260514","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/ije\/dyv080","article-title":"Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression.","volume":"44","author":"Bowden","year":"2015","journal-title":"Int J Epidemiol"},{"key":"R18-20260514","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1177\/0962280210394459","article-title":"Using multiple genetic variants as instrumental variables for modifiable risk factors.","volume":"21","author":"Palmer","year":"2012","journal-title":"Stat Methods Med Res"},{"key":"R19-20260514","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s10654-017-0255-x","article-title":"Interpreting findings from Mendelian randomization using the MR-Egger method.","volume":"32","author":"Burgess","year":"2017","journal-title":"Eur J Epidemiol"},{"key":"R20-20260514","doi-asserted-by":"crossref","first-page":"4851","DOI":"10.1093\/bioinformatics\/btz469","article-title":"PhenoScanner V2: an expanded tool for searching human genotype-phenotype associations.","volume":"35","author":"Kamat","year":"2019","journal-title":"Bioinformatics"},{"key":"R21-20260514","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41413-018-0024-9","article-title":"A peptide containing the receptor binding site of insulin-like growth factor binding protein-2 enhances bone mass in ovariectomized rats.","volume":"6","author":"Xi","year":"2018","journal-title":"Bone Res"},{"key":"R22-20260514","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/jcp.30919","article-title":"IGF2BP2, an RNA-binding protein regulates cell proliferation and osteogenic differentiation by stabilizing SRF mRNA.","volume":"238","author":"Zhou","year":"2023","journal-title":"J Cell Physiol"},{"key":"R23-20260514","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1172\/JCI1111","article-title":"Insulin-like growth factor system abnormalities in hepatitis C-associated osteosclerosis. Potential insights into increasing bone mass in adults.","volume":"101","author":"Khosla","year":"1998","journal-title":"J Clin Invest"},{"key":"R24-20260514","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/S1096-6374(02)00044-8","article-title":"Subcutaneous administration of insulin-like growth factor (IGF)-II\/IGF binding protein-2 complex stimulates bone formation and prevents loss of bone mineral density in a rat model of disuse osteoporosis.","volume":"12","author":"Conover","year":"2002","journal-title":"Growth Horm IGF Res"},{"key":"R25-20260514","doi-asserted-by":"crossref","first-page":"E648","DOI":"10.1152\/ajpendo.00049.2003","article-title":"Potentiating role of IGFBP-2 on IGF-II-stimulated alkaline phosphatase activity in differentiating osteoblasts.","volume":"286","author":"Palermo","year":"2004","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"R26-20260514","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s12079-015-0261-2","article-title":"IGFBP-2 - taking the lead in growth, metabolism and cancer.","volume":"9","author":"Yau","year":"2015","journal-title":"J Cell Commun Signal"},{"key":"R27-20260514","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1530\/eje.0.1310150","article-title":"No evidence for reduced spontaneous or growth-hormone-stimulated serum levels of insulin-like growth factor (IGF)-I, IGF-II or IGF binding protein 3 in women with spinal osteoporosis.","volume":"131","author":"Kassem","year":"1994","journal-title":"Eur J Endocrinol"},{"key":"R28-20260514","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1210\/en.2007-1068","article-title":"Gender-specific changes in bone turnover and skeletal architecture in igfbp-2-null mice.","volume":"149","author":"DeMambro","year":"2008","journal-title":"Endocrinology"},{"key":"R29-20260514","doi-asserted-by":"crossref","first-page":"11578","DOI":"10.1074\/jbc.M114.620237","article-title":"The coordinate cellular response to insulin-like growth factor-I (IGF-I) and insulin-like growth factor-binding protein-2 (IGFBP-2) is regulated through vimentin binding to receptor tyrosine phosphatase \u03b2 (RPTP\u03b2).","volume":"290","author":"Shen","year":"2015","journal-title":"J Biol Chem"},{"key":"R30-20260514","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1007\/s11914-012-0109-0","article-title":"Signaling pathways affecting skeletal health.","volume":"10","author":"Marie","year":"2012","journal-title":"Curr Osteoporos Rep"},{"key":"R31-20260514","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/s41387-018-0063-8","article-title":"Sex-specific correlation of IGFBP-2 and IGFBP-3 with vitamin D status in adults with obesity: a cross-sectional serum proteomics study.","volume":"8","author":"Al-Daghri","year":"2018","journal-title":"Nutr Diabetes"},{"key":"R32-20260514","doi-asserted-by":"crossref","first-page":"1222101","DOI":"10.3389\/fendo.2023.1222101","article-title":"Plasma IGFBP-2 levels reveal heterogeneity in hepatic fat content in adults with excess visceral adiposity.","volume":"14","author":"Rauzier","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R33-20260514","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.3390\/nu16111773","article-title":"Nutrition, vitamin D, and calcium in elderly patients before and after a hip fracture and their impact on the musculoskeletal system: a narrative review.","volume":"16","author":"Cianferotti","year":"2024","journal-title":"Nutrients"},{"key":"R34-20260514","doi-asserted-by":"crossref","first-page":"101122","DOI":"10.1016\/j.gendis.2023.101122","article-title":"The role of lipid metabolism in osteoporosis: Clinical implication and cellular mechanism.","volume":"11","author":"Zhang","year":"2023","journal-title":"Genes Dis"},{"key":"R35-20260514","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1210\/jcem.87.4.8426","article-title":"Musculoskeletal effects of the recombinant human IGF-I\/IGF binding protein-3 complex in osteoporotic patients with proximal femoral fracture: a double-blind, placebo-controlled pilot study.","volume":"87","author":"Boonen","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"R36-20260514","doi-asserted-by":"crossref","first-page":"2613766","DOI":"10.1155\/2023\/2613766","article-title":"Circulating IGFBP-3 and Interleukin 6 as Predictors of Osteoporosis in Postmenopausal Women: A Cross-Sectional Study.","volume":"2023","author":"Shi","year":"2023","journal-title":"Mediators Inflamm"},{"key":"R37-20260514","doi-asserted-by":"crossref","first-page":"e1552","DOI":"10.1210\/clinem\/dgaa963","article-title":"Insulin-like growth factor-1, bone mineral density, and fracture: a mendelian randomization study.","volume":"106","author":"Yuan","year":"2021","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000045227","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T11:05:56Z","timestamp":1778756756000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000045227"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,21]]},"references-count":37,"journal-issue":{"issue":"47","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000045227","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,21]]},"assertion":[{"value":"2025-05-09","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-22","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}